Letter to the editor: Cost of preventing retrolental fibroplasia.
作者信息
Barrie H
出版信息
Lancet. 1973 Dec 8;2(7841):1320. doi: 10.1016/s0140-6736(73)92888-2.
PMID:4127656
Abstract
摘要
相似文献
1
Letter to the editor: Cost of preventing retrolental fibroplasia.
Lancet. 1973 Dec 8;2(7841):1320. doi: 10.1016/s0140-6736(73)92888-2.
2
Letter: Cost of preventing retrolental fibroplasia.
Lancet. 1974 Apr 20;1(7860):746-7.
3
Further observations on cost of preventing retrolental fibroplasia.
Lancet. 1974 Mar 16;1(7855):445-8. doi: 10.1016/s0140-6736(74)92395-2.
4
Cost of preventing retrolental fibroplasia?
Lancet. 1973 Oct 27;2(7835):954-6. doi: 10.1016/s0140-6736(73)92610-x.
5
Current status of role of oxygen in retrolental fibroplasia.
Invest Ophthalmol. 1976 May;15(5):337-9.
6
[Problems of the prevention of retrolental fibroplasia].
Pediatr Pol. 1984 Jun;59(6):507-11.
7
The resurgence of retrolental fibroplasia.
Pediatr Clin North Am. 1970 May;17(2):309-22. doi: 10.1016/s0031-3955(16)32411-7.
8
[On problems of retrolental fibroplasia].
Ther Umsch. 1969 Jun;26(6):322-4.
9
Retrolental fibroplasia: an unsolved problem.
N Engl J Med. 1981 Dec 3;305(23):1404-6. doi: 10.1056/NEJM198112033052309.
10
Retrolental fibroplasia--a continuing program.
Trans Am Acad Ophthalmol Otolaryngol. 1970 Jan-Feb;74(1):18-27.
引用本文的文献
1
First day neonatal mortality since 1935: re-examination of the Cross hypothesis.
BMJ. 1992 Feb 8;304(6823):343-6. doi: 10.1136/bmj.304.6823.343.
Zotero 插件